AstraZeneca, Others Hit With Nexium Pay-For-Delay Suits
By Scott Flaherty ( August 27, 2012, 7:04 PM EDT) -- Three putative class actions filed Friday in Pennsylvania federal court accuse AstraZeneca PLC and several generic-drug makers of violating antitrust laws by entering agreements to delay entry of a generic version of AstraZeneca's heartburn drug Nexium....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.